Striving for better access to care
The Novo Nordisk Haemophilia Foundation (NNHF) is a grant-making, non-profit organisation dedicated to improving access to care for people with haemophilia and allied disorders in low- and middle-income countries.
NNHF is driven by its vision that all people with haemophilia and allied disorders receive care and treatment, wherever they live.
80% of people with haemophilia live in low- and middle-income countries. Many remain undiagnosed and unable to access quality care due to a widespread lack of knowledge about the disease among healthcare professionals, authorities, their own families and the public.
Established in 2005 in Zurich (Switzerland), the NNHF funds projects to build capacity for diagnosis and care, encouraging its partners to join forces for sustainable impact and systemic change. Untreated, people with haemophilia can suffer pain, disabilities and fatal complications.
Together, we strive to empower people with haemophilia and allied disorders to raise awareness, advocate with a united voice and live full lives.